Ethical AI guardrails are imperative for health care’s future. A new version of ...
"Despite a general meaningful aspiration to remain focused on the patient and th...
Universities and research institutions comment that the U.S. Office of Research ...
Senators are pushing the Biden administration to collect more data on #MedicareA...
News of the FDA's historic approval of the first gene therapies for sickle cell ...
Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional ma...
The combination therapy of MSD’s Keytruda (pembrolizumab) and Eisai’s Lenvima (...
Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial e...
Vanda Pharmaceuticals has acquired rights to Johnson & Johnson (J&J) company Ac...
The US Food and Drug Administration (FDA) has accepted Alpha Cognition’s new dr...
Clinical-stage radiopharmaceutical company ARTBIO has secured $90m in a Series ...
AbelZeta Pharma and AstraZeneca have signed an agreement to jointly develop...
Vittoria Biotherapeutics will begin in-human studies of its lead chimeric a...
The US Food and Drug Administration (FDA) has accepted Massachusetts-based Next...
The Biden administration has announced plans to allow agencies to use march-in ...
This week on "The Readout LOUD" podcast: How does the first CRISPR treatment wor...
